Your browser doesn't support javascript.
loading
Evolutionary history of human colitis-associated colorectal cancer.
Baker, Ann-Marie; Cross, William; Curtius, Kit; Al Bakir, Ibrahim; Choi, Chang-Ho Ryan; Davis, Hayley Louise; Temko, Daniel; Biswas, Sujata; Martinez, Pierre; Williams, Marc J; Lindsay, James O; Feakins, Roger; Vega, Roser; Hayes, Stephen J; Tomlinson, Ian P M; McDonald, Stuart A C; Moorghen, Morgan; Silver, Andrew; East, James E; Wright, Nicholas A; Wang, Lai Mun; Rodriguez-Justo, Manuel; Jansen, Marnix; Hart, Ailsa L; Leedham, Simon J; Graham, Trevor A.
Afiliação
  • Baker AM; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Cross W; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Curtius K; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Al Bakir I; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Choi CR; Inflammatory Bowel Disease Unit, St Mark's Hospital, London, UK.
  • Davis HL; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Temko D; Inflammatory Bowel Disease Unit, St Mark's Hospital, London, UK.
  • Biswas S; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Martinez P; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Williams MJ; Department of Computer Science, University College London, London, UK.
  • Lindsay JO; Centre for Mathematics and Physics in the Life Sciences and Experimental Biology (CoMPLEX), University College London, London, UK.
  • Feakins R; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Vega R; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Hayes SJ; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Tomlinson IPM; Centre for Mathematics and Physics in the Life Sciences and Experimental Biology (CoMPLEX), University College London, London, UK.
  • McDonald SAC; Department of Cell and Developmental Biology, University College London, London, UK.
  • Moorghen M; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Silver A; Department of Histopathology, The Royal London Hospital, London, UK.
  • East JE; Department of Gastroenterology, University College London Hospital, London, UK.
  • Wright NA; Department of Histopathology, Salford Royal NHS Foundation Trust, University of Manchester, Manchester, UK.
  • Wang LM; Cancer Genetics and Evolution Laboratory, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Rodriguez-Justo M; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Jansen M; Inflammatory Bowel Disease Unit, St Mark's Hospital, London, UK.
  • Hart AL; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Leedham SJ; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Graham TA; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Gut ; 68(6): 985-995, 2019 06.
Article em En | MEDLINE | ID: mdl-29991641
ABSTRACT

OBJECTIVE:

IBD confers an increased lifetime risk of developing colorectal cancer (CRC), and colitis-associated CRC (CA-CRC) is molecularly distinct from sporadic CRC (S-CRC). Here we have dissected the evolutionary history of CA-CRC using multiregion sequencing.

DESIGN:

Exome sequencing was performed on fresh-frozen multiple regions of carcinoma, adjacent non-cancerous mucosa and blood from 12 patients with CA-CRC (n=55 exomes), and key variants were validated with orthogonal methods. Genome-wide copy number profiling was performed using single nucleotide polymorphism arrays and low-pass whole genome sequencing on archival non-dysplastic mucosa (n=9), low-grade dysplasia (LGD; n=30), high-grade dysplasia (HGD; n=13), mixed LGD/HGD (n=7) and CA-CRC (n=19). Phylogenetic trees were reconstructed, and evolutionary analysis used to reveal the temporal sequence of events leading to CA-CRC.

RESULTS:

10/12 tumours were microsatellite stable with a median mutation burden of 3.0 single nucleotide alterations (SNA) per Mb, ~20% higher than S-CRC (2.5 SNAs/Mb), and consistent with elevated ageing-associated mutational processes. Non-dysplastic mucosa had considerable mutation burden (median 47 SNAs), including mutations shared with the neighbouring CA-CRC, indicating a precancer mutational field. CA-CRCs were often near triploid (40%) or near tetraploid (20%) and phylogenetic analysis revealed that copy number alterations (CNAs) began to accrue in non-dysplastic bowel, but the LGD/HGD transition often involved a punctuated 'catastrophic' CNA increase.

CONCLUSIONS:

Evolutionary genomic analysis revealed precancer clones bearing extensive SNAs and CNAs, with progression to cancer involving a dramatic accrual of CNAs at HGD. Detection of the cancerised field is an encouraging prospect for surveillance, but punctuated evolution may limit the window for early detection.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Colite Ulcerativa / Transformação Celular Neoplásica Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Colite Ulcerativa / Transformação Celular Neoplásica Idioma: En Ano de publicação: 2019 Tipo de documento: Article